Bioage Labs Inc (BIOA)
4.34 +0.11 (+2.60%) 13:22 ET [NASDAQ]
4.37 x 100 4.39 x 300
Realtime by (Cboe BZX)
4.37 x 100 4.39 x 300
Realtime - - (-) -
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||
| Net Income | -71,109 | -63,854 |
| Depreciation Amortization | 167 | 162 |
| Accounts payable and accrued liabilities | 6 | -393 |
| Other Working Capital | 11,176 | 6,710 |
| Other Operating Activity | 8,238 | 20,013 |
| Operating Cash Flow | $-51,522 | $-37,362 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -366 | -166 |
| Purchase Of Investment | N/A | -100 |
| Investing Cash Flow | $-366 | $-266 |
| Cash Flows From Financing Activities | ||
| Debt Issued | -6,000 | 35,000 |
| Common Stock Issued | 222,253 | 4 |
| Other Financing Activity | 164,946 | -63 |
| Financing Cash Flow | $381,199 | $34,941 |
| Exchange Rate Effect | 81 | N/A |
| Beginning Cash Position | 24,957 | 27,644 |
| End Cash Position | 354,349 | 24,957 |
| Net Cash Flow | $329,392 | $-2,687 |
| Free Cash Flow | ||
| Operating Cash Flow | -51,522 | -37,362 |
| Capital Expenditure | -366 | -166 |
| Free Cash Flow | -51,888 | -37,528 |